Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorder.
D000379:Agoraphobia / Q000150:complications / Q000188:drug therapy*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002997:Clomipramine / Q000627:therapeutic use; D003863:Depression / Q000150:complications; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009661:Nortriptyline / Q000627:therapeutic use; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000188:drug therapy*; D010624:Phenelzine / Q000627:therapeutic use; D010698:Phobic Disorders / Q000188:drug therapy*
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D009661:Nortriptyline; D002997:Clomipramine; D010624:Phenelzine; D007099:Imipramine